Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $526.33 million. The enterprise value is $539.66 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 132.58 million shares outstanding. The number of shares has decreased by -0.37% in one year.
| Current Share Class | 132.58M |
| Shares Outstanding | 132.58M |
| Shares Change (YoY) | -0.37% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 35.08% |
| Owned by Institutions (%) | 39.85% |
| Float | 63.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 72.18 |
| PS Ratio | 1.15 |
| Forward PS | 1.06 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | 135.30 |
| P/OCF Ratio | 37.91 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 18.78, with an EV/FCF ratio of 138.73.
| EV / Earnings | n/a |
| EV / Sales | 1.19 |
| EV / EBITDA | 18.78 |
| EV / EBIT | 45.17 |
| EV / FCF | 138.73 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.39.
| Current Ratio | 3.09 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 2.31 |
| Debt / FCF | 27.68 |
| Interest Coverage | 5.67 |
Financial Efficiency
Return on equity (ROE) is -2.66% and return on invested capital (ROIC) is 1.90%.
| Return on Equity (ROE) | -2.66% |
| Return on Assets (ROA) | 1.64% |
| Return on Capital (ROIC) | 1.90% |
| Revenue Per Employee | $527,886 |
| Profits Per Employee | -$8,561 |
| Employee Count | 862 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 4.09 |
Taxes
| Income Tax | -7.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.81% in the last 52 weeks. The beta is 1.60, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +49.81% |
| 50-Day Moving Average | 3.11 |
| 200-Day Moving Average | 2.90 |
| Relative Strength Index (RSI) | 63.40 |
| Average Volume (20 Days) | 672,100 |
Short Selling Information
The latest short interest is 9.79 million, so 7.39% of the outstanding shares have been sold short.
| Short Interest | 9.79M |
| Short Previous Month | 10.30M |
| Short % of Shares Out | 7.39% |
| Short % of Float | 15.52% |
| Short Ratio (days to cover) | 23.59 |
Income Statement
In the last 12 months, ORGO had revenue of $455.04 million and -$7.38 million in losses. Loss per share was -$0.06.
| Revenue | 455.04M |
| Gross Profit | 342.58M |
| Operating Income | 11.95M |
| Pretax Income | -13.04M |
| Net Income | -7.38M |
| EBITDA | 28.74M |
| EBIT | 11.95M |
| Loss Per Share | -$0.06 |
Full Income StatementBalance Sheet
The company has $94.34 million in cash and $107.67 million in debt, giving a net cash position of -$13.33 million or -$0.10 per share.
| Cash & Cash Equivalents | 94.34M |
| Total Debt | 107.67M |
| Net Cash | -13.33M |
| Net Cash Per Share | -$0.10 |
| Equity (Book Value) | 278.55M |
| Book Value Per Share | 2.10 |
| Working Capital | 161.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $13.89 million and capital expenditures -$10.00 million, giving a free cash flow of $3.89 million.
| Operating Cash Flow | 13.89M |
| Capital Expenditures | -10.00M |
| Free Cash Flow | 3.89M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 75.29%, with operating and profit margins of 2.63% and -1.62%.
| Gross Margin | 75.29% |
| Operating Margin | 2.63% |
| Pretax Margin | -3.26% |
| Profit Margin | -1.62% |
| EBITDA Margin | 6.32% |
| EBIT Margin | 2.63% |
| FCF Margin | 1.90% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.37% |
| Shareholder Yield | 0.37% |
| Earnings Yield | -1.40% |
| FCF Yield | 0.74% |
Analyst Forecast
The average price target for ORGO is $5.33, which is 34.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.33 |
| Price Target Difference | 34.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 2.77 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.77 |
| Piotroski F-Score | 6 |